+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liposomal Drug Delivery Devices Global Market Report 2024

  • PDF Icon

    Report

  • 250 Pages
  • February 2024
  • Region: Global
  • The Business Research Company
  • ID: 5733886
The liposomal drug delivery devices market size has grown rapidly in recent years. It will grow from $4.52 billion in 2023 to $5.02 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The growth observed in the historical period can be attributed to several factors, including advancements in drug delivery techniques, biomedical research progress, clinical validation of these methods, diverse therapeutic applications, and improvements in biocompatibility, collectively contributing to the expansion of liposomal drug delivery devices.

The liposomal drug delivery devices market size is expected to see rapid growth in the next few years. It will grow to $7.71 billion in 2028 at a compound annual growth rate (CAGR) of 11.4%. Anticipated growth is from targeted therapies, clinical trials, personalized medicine focus, combination therapies, and regulatory changes. Trends include biocompatible materials, delivery innovations, oncology applications, combination therapies, and customized formulations in liposomal drug delivery.

The escalating global incidence of cancer cases is poised to be a driving factor in the growth of the liposomal drug delivery devices market during the forecast period. Liposomal drug delivery systems play a pivotal role in targeted cancer therapy, encompassing radiation therapy, chemotherapy, and surgical resection. Notably, the American Cancer Society reported 1.9 million new cancer cases and 0.6 million cancer-related deaths in the USA in 2021. With lung, prostate, bowel, and female breast cancer collectively constituting 43% of all new cases globally, the surge in cancer rates worldwide is expected to significantly enhance the demand for liposomal drug delivery devices in the coming years.

The anticipated upswing in healthcare expenditure is set to propel the expansion of the liposomal drug delivery devices market. Factors contributing to the rise in healthcare spending include the heightened prevalence of chronic diseases, advancements in medical technology, escalating drug prices, consumer expectations, and increasing insurance costs. Healthcare expenditure encompasses various facets, including research, development, manufacturing, distribution, and utilization of medical technologies such as liposomal drug delivery systems. In July 2022, the Peter G Foundation projected that both public and private healthcare spending in the United States would increase from $4.4 trillion in 2022 to $7.2 trillion in 2031. This rise in expenditure, outpacing economic growth, is anticipated to foster the growth of the liposomal drug delivery devices market.

The elevated cost associated with liposomal drug delivery devices is expected to impede the market's growth during the forecast period. The high cost of these devices renders liposomal treatments prohibitively expensive for patients, posing a constraint on market expansion. Notably, lipid/liposomal drug delivery systems are reported to be costly to produce, attributed to the high production cost associated with raw materials such as lipid excipients and the necessity for expensive equipment in the manufacturing process. Moreover, according to the ScienceDirect Journal, liposomal drug delivery stands out as the most expensive treatment for topical disorders such as psoriasis, atopic dermatitis, and skin cancer.

Prominent companies in the liposomal drug delivery devices market are actively engaging in strategic initiatives such as collaborations and new product development, emerging as a prevailing trend in the industry. These companies are forming partnerships to jointly develop liposomal drug delivery systems, aiming to broaden their product portfolios and enhance global operations. A notable example is the collaboration between MindMed, an Israeli creative drug development company, and Nextage, where a Memorandum of Understanding was executed in 2021. This collaboration focused on optimizing the supply of specific psychedelic drug candidates using Nextage's proprietary Brain Targeting Liposome System (BTLS) supply technology, under license.

Major players in the liposomal drug delivery market are introducing innovative products, including liposomal nanostructures, as a strategic move to gain a competitive advantage. Researchers are dedicated to developing liposomal nanostructures designed to enhance patient compliance by allowing less frequent doses while maintaining efficacy. An illustrative example comes from February 2022, where commercial nano-liposomal products, such as Onivyde, Vyxeos, and Marqibo, have been introduced and approved for use. These medications, employed in the treatment of cancer, specifically address certain types of leukemia or solid tumors. Onivyde, Vyxeos, and Marqibo play a critical role in oncology by offering treatment options for specific cancer types resistant to conventional chemotherapy or requiring liposomal drug delivery.

In December 2021, AstraZeneca, a UK-headquartered research-based biopharmaceutical firm, entered into a collaboration with professors Fredrik Höök and Elin Esbjörner of Chalmers University of Technology in Sweden, the terms of which were not disclosed. The collaboration is specifically oriented towards advancing the field of lipid nanoparticles (LNPs) for intracellular transport of nucleotide-based therapeutics, as well as the efficient production of protein therapeutics within cells. The partnership leverages the expertise of Fredrik Höök and Elin Esbjörner, who hold positions as professors at Chalmers University of Technology, a distinguished private research university based in Sweden.

Major companies operating in the liposomal drug delivery devices market report are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Novartis AG, Medtronic PLC, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Mylan NV, Sun Pharmaceutical Industries Ltd., CSPC Pharmaceutical Group Limited, Ipsen SA, Novavax Inc., Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co. Ltd., Nanomerics Ltd., Luye Pharma Group Ltd., Leadiant Biosciences Inc., Pacira Biosciences Inc., Tolmar Pharmaceuticals Inc., Nippon Kayaku Co. Ltd., Celsion Corporation, Acrotech Biopharma Inc., Aphios Pharma LLC, CytImmune Sciences Inc., NanoSphere Health Sciences Inc., Cel-Sci Corporation, Lipoid GmbH, Liposome Company Inc., Liposome Research Days Corporation, Taiwan Liposome Company, T&T Scientific Corporation. North America was the largest region in the liposomal drug delivery devices market in 2023. Asia-Pacific was the second-largest region in the global liposomal drug delivery devices market share. The regions covered in the liposomal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Primary types encompass liposomal doxorubicin, liposomal paclitaxel, liposomal amphotericin B, and others. Liposomal doxorubicin, a chemotherapy drug under the anthracycline category, encapsulated within a liposome, inhibits cancer cell growth by blocking the enzyme topoisomerase. These devices find applications in treating fungal diseases, cancer therapy, pain management, viral vaccines, and photodynamic therapy, utilized in hospitals, diagnostic centers, ambulatory surgery centers/clinics, and similar medical settings.

The liposomal drug delivery devices market research report is one of a series of new reports that provides liposomal drug delivery devices market statistics, including liposomal drug delivery devices industry global market size, regional shares, competitors with a liposomal drug delivery devices market share, detailed liposomal drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the liposomal drug delivery devices industry. This liposomal drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The countries covered in the liposomal drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The liposomal drug delivery devices market consists of sales of instruments such as liposomal doxorubicin, liposomal paclitaxel, liposomal amphotericin B, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary2. Liposomal Drug Delivery Devices Market Characteristics3. Liposomal Drug Delivery Devices Market Trends and Strategies
4. Liposomal Drug Delivery Devices Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Liposomal Drug Delivery Devices Market Size and Growth
5.1. Global Liposomal Drug Delivery Devices Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Liposomal Drug Delivery Devices Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Liposomal Drug Delivery Devices Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Liposomal Drug Delivery Devices Market Segmentation
6.1. Global Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Liposomal Doxorubicin
  • Liposomal Paclitaxel
  • Liposomal Amphotericin B
  • Other Types
6.2. Global Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Fungal Diseases
  • Cancer Therapy
  • Pain Management
  • Viral Vaccines
  • Photodynamic Therapy
6.3. Global Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers/Clinics
  • Other End Users
7. Liposomal Drug Delivery Devices Market Regional and Country Analysis
7.1. Global Liposomal Drug Delivery Devices Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Liposomal Drug Delivery Devices Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Liposomal Drug Delivery Devices Market
8.1. Asia-Pacific Liposomal Drug Delivery Devices Market Overview
Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Liposomal Drug Delivery Devices Market
9.1. China Liposomal Drug Delivery Devices Market Overview
9.2. China Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Liposomal Drug Delivery Devices Market
10.1. India Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Liposomal Drug Delivery Devices Market
11.1. Japan Liposomal Drug Delivery Devices Market Overview
11.2. Japan Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Liposomal Drug Delivery Devices Market
12.1. Australia Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Liposomal Drug Delivery Devices Market
13.1. Indonesia Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Liposomal Drug Delivery Devices Market
14.1. South Korea Liposomal Drug Delivery Devices Market Overview
14.2. South Korea Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Liposomal Drug Delivery Devices Market
15.1. Western Europe Liposomal Drug Delivery Devices Market Overview
15.2. Western Europe Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Liposomal Drug Delivery Devices Market
16.1. UK Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Liposomal Drug Delivery Devices Market
17.1. Germany Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Liposomal Drug Delivery Devices Market
18.1. France Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Liposomal Drug Delivery Devices Market
19.1. Italy Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Liposomal Drug Delivery Devices Market
20.1. Spain Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Liposomal Drug Delivery Devices Market
21.1. Eastern Europe Liposomal Drug Delivery Devices Market Overview
21.2. Eastern Europe Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Liposomal Drug Delivery Devices Market
22.1. Russia Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Liposomal Drug Delivery Devices Market
23.1. North America Liposomal Drug Delivery Devices Market Overview
23.2. North America Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Liposomal Drug Delivery Devices Market
24.1. USA Liposomal Drug Delivery Devices Market Overview
24.2. USA Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Liposomal Drug Delivery Devices Market
25.1. Canada Liposomal Drug Delivery Devices Market Overview
25.2. Canada Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Liposomal Drug Delivery Devices Market
26.1. South America Liposomal Drug Delivery Devices Market Overview
26.2. South America Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Liposomal Drug Delivery Devices Market
27.1. Brazil Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Liposomal Drug Delivery Devices Market
28.1. Middle East Liposomal Drug Delivery Devices Market Overview
28.2. Middle East Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Liposomal Drug Delivery Devices Market
29.1. Africa Liposomal Drug Delivery Devices Market Overview
29.2. Africa Liposomal Drug Delivery Devices Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Liposomal Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Liposomal Drug Delivery Devices Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Liposomal Drug Delivery Devices Market Competitive Landscape and Company Profiles
30.1. Liposomal Drug Delivery Devices Market Competitive Landscape
30.2. Liposomal Drug Delivery Devices Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Johnson & Johnson Services Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Merck & Co. Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Novartis AG
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Medtronic plc
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Liposomal Drug Delivery Devices Market Other Major and Innovative Companies
31.1. Gilead Sciences Inc.
31.2. Teva Pharmaceutical Industries Ltd.
31.3. Mylan NV
31.4. Sun Pharmaceutical Industries Ltd.
31.5. CSPC Pharmaceutical Group Limited
31.6. Ipsen SA
31.7. Novavax Inc.
31.8. Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co. Ltd.
31.9. Nanomerics Ltd.
31.10. Luye Pharma Group Ltd.
31.11. Leadiant Biosciences Inc.
31.12. Pacira Biosciences Inc.
31.13. Tolmar Pharmaceuticals Inc.
31.14. Nippon Kayaku Co. Ltd.
31.15. Celsion Corporation
32. Global Liposomal Drug Delivery Devices Market Competitive Benchmarking33. Global Liposomal Drug Delivery Devices Market Competitive Dashboard34. Key Mergers and Acquisitions in the Liposomal Drug Delivery Devices Market
35. Liposomal Drug Delivery Devices Market Future Outlook and Potential Analysis
35.1 Liposomal Drug Delivery Devices Market in 2028 - Countries Offering Most New Opportunities
35.2 Liposomal Drug Delivery Devices Market in 2028 - Segments Offering Most New Opportunities
35.3 Liposomal Drug Delivery Devices Market in 2028 - Growth Strategies
35.3.1 Market Trend-based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

Liposomal Drug Delivery Devices Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on liposomal drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
  • Report will be updated with the latest data and delivered to you with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for liposomal drug delivery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Report Scope

Markets Covered:
1) By Type: Liposomal Doxorubicin; Liposomal Paclitaxel; Liposomal Amphotericin B; Other Types
2) By Application: Fungal Diseases; Cancer Therapy; Pain Management; Viral Vaccines; Photodynamic Therapy
3) By End-user: Hospitals; Diagnostic Centers; Ambulatory Surgery Centers/Clinics; Other End-users

Key Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Merck & Co. Inc.; Novartis AG; Medtronic plc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Pfizer Inc.
  • Johnson & Johnson Services Inc.
  • Merck & Co. Inc.
  • Novartis AG
  • Medtronic plc
  • Gilead Sciences Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan NV
  • Sun Pharmaceutical Industries Ltd.
  • CSPC Pharmaceutical Group Limited
  • Ipsen SA
  • Novavax Inc.
  • Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co. Ltd.
  • Nanomerics Ltd.
  • Luye Pharma Group Ltd.
  • Leadiant Biosciences Inc.
  • Pacira Biosciences Inc.
  • Tolmar Pharmaceuticals Inc.
  • Nippon Kayaku Co. Ltd.
  • Celsion Corporation
  • Acrotech Biopharma Inc.
  • Aphios Pharma LLC
  • CytImmune Sciences Inc.
  • NanoSphere Health Sciences Inc.
  • Cel-Sci Corporation
  • Lipoid GmbH
  • Liposome Company Inc.
  • Liposome Research Days Corporation
  • Taiwan Liposome Company
  • T&T Scientific Corporation

Methodology

Loading
LOADING...

Table Information